Total investments received (USD): 91.74m
Round value (USD): 3m
Round investors:
Novo Seeds
Company: Antag Therapeutics
Industry:
Biotech
Health services

Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom